Key result
The visual RT-PSR assay demonstrated 100% positive and negative agreement with quantitative RT-PCR for detecting Coxsackievirus A6 in clinical throat swab samples.
Why the study?
Coxsackievirus A6 is a primary enterovirus linked to hand-foot-mouth disease and herpangina, creating an urgent need for an efficient identification method.
Does the RT-PSR assay accurately and rapidly detect Coxsackievirus A6 in clinical throat swab samples compared to qRT-PCR?
Does the RT-PSR assay accurately and rapidly detect Coxsackievirus A6 in clinical throat swab samples compared to qRT-PCR?
Effect estimate: Kappa 1
Absolute Event Rate: 100% vs 100%
The RT-PSR assay with HNB provides a rapid, sensitive, and specific visual detection method for Coxsackievirus A6 in clinical samples.
Supports rapid visual CVA6 detection in throat swabs; leaves open larger prospective validation before routine use.
Coxsackievirus A6 (CVA6) ranks as a primary enterovirus associated with hand-foot-mouth disease (HFMD) and herpangina (HA). Given its significant role in these diseases, there is an urgent need for an efficient identification method. This study presents a novel visual approach based on the reverse transcription polymerase spiral reaction (RT-PSR) for the rapid detection of CVA6. We designed an RT-PSR assay that targets and amplifies a segment of the VP1 gene. Hydroxy naphthol blue (HNB) is incorporated as the detection agent in this assay. To evaluate the performance of the RT-PSR assay, we analyzed 142 clinical throat swab samples. The results were benchmarked against those obtained using quantitative reverse transcription - polymerase chain reaction (qRT - PCR). The RT-PSR assay operates at 65°C for 60 minutes and exhibits a detection limit of 10 copies/μL. When tested against other viruses, it consistently yielded negative results, demonstrating its high specificity. Moreover, the RT - PSR assay showed excellent agreement with a commercial qRT - PCR kit. In conclusion, by using HNB as an indicator, the RT - PSR assay emerges as a straightforward and highly sensitive method for detecting CVA6 in symptomatic throat samples. This approach holds great potential for improving the diagnosis and surveillance of CVA6 - related diseases.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied Coxsackievirus A6 infection (n=142). Reverse transcription polymerase spiral reaction (RT-PSR) assay vs. TaqMan Real-Time RT-PCR was evaluated on Diagnostic agreement with quantitative RT-PCR (Kappa 1). The visual RT-PSR assay demonstrated 100% positive and negative agreement with quantitative RT-PCR for detecting Coxsackievirus A6 in clinical throat swab samples.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: